Hofstee H M A, Vonk Noordegraaf A, Voskuyl A E, Dijkmans B A C, Postmus P E, Smulders Y M, Serné E H
Department of Internal Medicine, VU University Medical Centre, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.
Ann Rheum Dis. 2009 Feb;68(2):191-5. doi: 10.1136/ard.2007.087353. Epub 2008 Mar 28.
The aim of this study was to investigate whether there are differences in capillary nailfold changes in patients with systemic sclerosis (SSc) with and without pulmonary arterial hypertension (PAH), and whether these changes are associated with PAH severity and disease specificity.
Capillary density and loop dimensions were studied in 21 healthy controls, 20 patients with idiopathic PAH (IPAH) and 40 patients with SSc. Of the 40 patients with SSc, 19 had no PAH (SSc-nonPAH) and 21 had PAH (SSc-PAH), of whom eight had PAH during exercise.
Capillary density was lower in SSc-PAH compared with patients who had SSc-nonPAH (4.33/mm vs 6.56/mm respectively, p = 0.001), but loop dimensions were equal. In comparison with IPAH, patients with SSc-PAH had reduced capillary density (4.33/mm vs 7.86/mm, p<0.001) and larger loop dimensions (total width 101.05 microm vs 44.43 microm, p<0.001). Capillary density in healthy controls (9.87/mm) was significantly higher when compared with SSc-nonPAH (6.56/mm), SSc-PAH (4.33/mm) and with IPAH (7.86/mm). No differences in capillary dimensions were present between healthy controls and IPAH. Capillary density correlated with mean pulmonary arterial pressure (PAP) at rest in SSc-PAH at rest (r = -0.58, p = 0.039) and IPAH (r = -0.67, p = 0.001).
Reduction of nailfold capillary density, but not capillary loop dimensions is associated with PAH, and correlates with the severity of PAH in both SSc and IPAH. This suggests that either systemic microvascular changes play a part in the development of PAH, or that PAH itself contributes to systemic microvascular changes.
本研究旨在调查系统性硬化症(SSc)合并和不合并肺动脉高压(PAH)患者的甲襞毛细血管变化是否存在差异,以及这些变化是否与PAH严重程度和疾病特异性相关。
对21名健康对照者、20名特发性PAH(IPAH)患者和40名SSc患者的毛细血管密度和袢尺寸进行了研究。在40名SSc患者中,19名无PAH(SSc-非PAH),21名有PAH(SSc-PAH),其中8名在运动时有PAH。
与SSc-非PAH患者相比,SSc-PAH患者的毛细血管密度较低(分别为4.33/mm和6.56/mm,p = 0.001),但袢尺寸相等。与IPAH相比,SSc-PAH患者的毛细血管密度降低(4.33/mm对7.86/mm,p<0.001),袢尺寸更大(总宽度101.0微 米对44.43微米,p<0.001)。健康对照者的毛细血管密度(9.87/mm)与SSc-非PAH(6.56/mm)、SSc-PAH(4.33/mm)和IPAH(7.86/mm)相比显著更高。健康对照者和IPAH之间的毛细血管尺寸无差异。SSc-PAH静息时的毛细血管密度与静息时的平均肺动脉压(PAP)相关(r = -0.58,p = 0.039),IPAH中也是如此(r = -0.67,p = 0.001)。
甲襞毛细血管密度降低而非毛细血管袢尺寸与PAH相关,并且在SSc和IPAH中均与PAH严重程度相关。这表明全身微血管变化要么在PAH的发生中起作用,要么PAH本身导致全身微血管变化。